ANI Pharmaceuticals
ANIP
#5234
Rank
C$2.41 B
Marketcap
C$105.32
Share price
2.65%
Change (1 day)
-16.24%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): C$6.72

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$6.88. In 2025 the company made an earnings per share (EPS) of C$4.99 an increase over its 2024 EPS that were of C-$1.60.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.7234.79%
2025C$4.99-412.5%
2024C-$1.60
2022C-$4.33-6.46%
2021C-$4.6372.87%
2020C-$2.68-476%
2019C$0.71-62.12%
2018C$1.88
2015C$1.91-47.66%
2014C$3.65-142.11%
2013C-$8.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$9.49 37.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.08-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$10.35 50.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$21.74 215.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
C-$3.59-152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.20-190.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.90-86.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
C$2.67-61.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
C-$36.03-623.40%๐Ÿ‡บ๐Ÿ‡ธ USA